03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Susan Rhee: no photograph is held, so the academic plate is shown instead.
Academic
Susan Rhee
Lead researcher in Regeneron's clinical trials
1
0
1
0
Aug 2026Sept 2026Oct 2026Nov 2026to date
2
press citations on 1 topic since 19 Aug 2026 · last quoted 29 Oct 2026
02 Quoted on · 1 of 29 topics
Susan Rhee: key facts
- Kind of voice
- Academic
- Role
- Lead researcher in Regeneron's clinical trials
- Quoted on
- Rare diseases
- Tracked press citations
- 2
- Most recently quoted
- 29 Oct 2026
- First quoted
- 19 Aug 2026
04 The signal · where Susan Rhee sits on rare diseases
Ranked 25= of 100 voices quoted in the press on rare diseases, level with 23 others on 2 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
- 2Dr Harrison CarterAcademicDirector of Screening at NHS England8
- 3=
Prof Dame Sue HillRegulatorChief Scientific Officer for England and Senior Responsible Officer for Genomics, NHS England7 - 25=Dr Manjeet ShehmarClinicianMedical Director, Nottingham University Hospitals NHS Trust2
- 25=Clare LivingstoneSector leaderHead of Professional Policy and Practice, Royal College of Midwives2
- 25=Susan RheeAcademicLead researcher in Regeneron's clinical trials2
- 25=Natalie KhoazClinicianResearch Midwife and Principal Investigator of the Generation Study at Jessop Wing, Sheffield Teaching Hospitals NHS Foundation Trust2
- 25=Russell WellsSector leaderFourth-year medical student at OHSU and lead author of the study2
Showing the leaders and the ranks around 25=, of 100 voices · See every voice on the topic →
05 On the record · press
What Susan Rhee has said
By outlet · linked articles
- fiercepharma.com1
- nytimes.com1
Where Susan Rhee has been quoted
- 01These Patients Struggle With Runaway Bones. Finally There’s Hope.nytimes.com · 29 Oct 2026
- 02Regeneron's Pasatru scores FDA approval in ultrarare bone lesions disorderfiercepharma.com · 19 Aug 2026
Verbatim
“There's a huge scientific engine that is looking at how we can apply these learnings to other disease areas.”
“It is a particularly cruel disease that is very unpredictable.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.